NewsBenzinga니덤, 뉴타닉스 투자의견 ‘매수’ 유지···목표주가 90달러로 상향 니덤, 뉴타닉스 투자의견 ‘매수’ 유지···목표주가 90달러로 상향 Benzinga 2026.09.28 09:56 (GMT+0) Open on Benzinga Other news PDS Biotechnology Corporation (PDSB) Discusses PDS-0301 Immunocytokine and Its Role in Treating Metastatic Colorectal Cancer - Slideshow (NASDAQ:PDSB) 2026-10-17 What to Expect From Advanced Micro Devices’ Q3 2026 Earnings Report Here's What to Expect From Uber’s Next Earnings Report Aflac’s Q3 2026 Earnings: What to Expect Marathon Petroleum Earnings Preview: What to Expect American International Group’s Quarterly Earnings Preview: What You Need to Know
PDS Biotechnology Corporation (PDSB) Discusses PDS-0301 Immunocytokine and Its Role in Treating Metastatic Colorectal Cancer - Slideshow (NASDAQ:PDSB) 2026-10-17